Transition of Renal Patients Using AlloSure Into Community Kidney Care
Public ClinicalTrials.gov record NCT04601155. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Patients undergoing kidney transplantation alone (either de-novo or re-transplant) at a participating hospital are routinely surveyed with interval blood tests as part of standard post-operative care through outpatient consultation. These tests include serum creatinine, blood sugar as well as DSA testing at various intervals. The ability to screen patients to better identify those who may be at risk of developing an adverse event using AlloSure cfDNA is likely to be advantageous, with the potential to improve graft survival and outcomes for transplant patients. The addition of AlloSure to the interventional group will be the focus of this study. Patients will have quarterly AlloSure cfDNA testing (every 3 months) and DSA as part of their post-transplant surveillance for a period of 5 years.Participants will attend outpatient visits/follow-up visits as part of their standard care, these will include appointments where they will have blood tests taken as part of post-transplant surveillance. For AlloSure cfDNA and DSA, blood will be taken quarterly.
Study identification
- NCT ID
- NCT04601155
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 248 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 18, 2020
- Primary completion
- Mar 23, 2023
- Completion
- Oct 5, 2023
- Last update posted
- Nov 2, 2023
2020 – 2023
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Amicis Research Center | Fairfield | California | 94533 | — |
| The Medical Research Group - Fresno | Fresno | California | 93720 | — |
| Amicis Research Center | Granada Hills | California | 91344 | — |
| Amicis Research Center | Mission Hills | California | 91345 | — |
| California Institute of Renal Research (Balboa) | San Diego | California | 92123 | — |
| Starling Physicians | Hartford | Connecticut | 06106 | — |
| George Washington/Medical Faculty Associates Inc. | Washington D.C. | District of Columbia | 20037 | — |
| Physician Consultants of Georgia | Macon | Georgia | 31201 | — |
| NANI Research | Hinsdale | Illinois | 60521 | — |
| NANI Research | Fort Wayne | Indiana | 46804 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| PRINE Health | Manhasset | New York | 11030 | — |
| Chinatown Kidney | New York | New York | 10013 | — |
| Nephrology Associates PC, Queens | Queens | New York | 11355 | — |
| Sholer Chris MD | Oklahoma City | Oklahoma | 73116 | — |
| Utah Kidney Research Institute | South Ogden | Utah | 84403 | — |
| Lynchburg Nephrology Physicians, PLLC | Lynchburg | Virginia | 24501 | — |
| Mendez Center for Clinical Research | Woodbridge | Virginia | 22192 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04601155, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04601155 live on ClinicalTrials.gov.